The U.S. Health Secretary emphasizes the following points about India as a pharma partner:

• India is seen as an 'indispensable' partner in the pharmaceutical industry, given its significant contribution to the global supply chain.
• India has a strong pharmaceutical manufacturing sector and is known for its production of generic drugs, which are vital in providing affordable healthcare options.
• However, the U.S. Health Secretary highlights the importance of meeting U.S. drug standards to ensure the safety, efficacy, and quality of medications that enter the American market.
• Meeting these standards would ensure that medications produced in India are safe and effective for patients in the United States.
• Collaboration and cooperation between India and the United States in the pharmaceutical sector are essential in maintaining a robust global drug supply chain.

In summary, the U.S. Health Secretary acknowledges India's importance as a pharma partner but emphasizes the need to adhere to U.S. drug standards for ensuring patient safety and quality medications.